Go to deals
Healthcare

Oakleaf Care (Hartwell) Limited has been acquired by CareTech Holdings Plc

The private shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) have sold the company to CareTech Holdings Plc (CareTech) for an undisclosed consideration.

Oakleaf Care provides brain injury rehabilitation to adult males requiring specialist care and long-term support. Based in Northamptonshire, UK, the group operates over 80 beds across a number of sites, with highly trained staff providing a seamless rehabilitation pathway of care for men with acquired brain injury (ABI). The business continues to expand, with a new 22-bed care home opening this quarter bringing the total to over 100 beds.

CareTech is a provider of specialist social care services in the UK, supporting adults and children with a wide range of complex needs across more than 250 specialist services. This acquisition gives CareTech a presence in ABI rehabilitation, enabling it to offer additional pathways to its client care group.

Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.

Parties

Talk to the deal team

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Related deals

MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more
SLT has been acquired by Indutrade
Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more